Industry Relations Council Participants


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Patient Assistance Program: Access360 (patient assistance/insurance investigation)
Patient Assistance Program: AZ & me (prescription savings)
Clinical Trials >

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.

Patient Assistance Program: BMS Access Support
Clinical Trials >

A Leading Global Research and Development-Based Pharmaceutical Company Headquartered in Japan
Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing  and marketing, with a strong focus on prescription medicines.
Patient Assistance Program: Ease.US
Clinical Trials >

G1 Therapeutics is a global biopharmaceutical company with a mission to discover, develop and deliver innovative therapies that improve the lives of those affected by cancer. We are led by a team with a deep understanding of the biology of cancer and extensive drug discovery, development and commercialization experience, we are rapidly advancing two novel therapies for people living with cancer.
Patient Assistance Program: G1 to One
Clinical Trials >

At Genentech, we’re fundamentally transforming the way cancer is treated, with the goal of moving cancer toward a more manageable disease. Our commitment to this goal has enabled us to make significant contributions to the understanding of cancer and to translate this understanding into targeted, biologic-based therapies.
Patient Assistance Program: Genentech Access Solutions
Clinical Trials >

GSK is focused on maximizing patient survival through transformational medicines. GSK’s oncology pipeline is focused on immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality. Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines utilizing modalities such as small molecules, antibodies, antibody drug conjugates and cells, either alone or in combination.
Patient Assistance Program: Together with GSK Oncology
Clinical Trials >

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.
Patient Assistance Program:
Clinical Trials >

For more than five decades, Lilly Oncology has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches that accelerate the pace and progress of cancer care. We also understand cancer care is complex, and we’re working to provide support services that are meaningful for you and your patients.
Patient Assistance Program: Patient One Program

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time.
Patient Assistance Program: Pfizer RxPathways
Clinical Trials >

Sandoz, with three decades developing and manufacturing biologics, is the global leader in biosimilars. Sandoz biosimilars are marketed in 60 countries with over 300 million patient days of experience. With the March 6, 2015 approval of a biosimilar in the US, we continue to demonstrate our determination to bring high quality affordable medicines to the community.

Teva Pharmaceutical Industries Ltd. has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area.
Patient Assistance Program: Teva CORE